Three Sides to the Story: Adherence Trajectories During the First Year of SGLT2 Inhibitor Therapy Among Medicare Beneficiaries

Three Sides to the Story: Adherence Trajectories During the First Year of SGLT2 Inhibitor Therapy Among Medicare Beneficiaries

OBJECTIVE: We aimed to understand the factors associated with sodium-glucose cotransporter 2 inhibitor (SGLT2i) adherence and longitudinal adherence trajectories in older adults with type 2 diabetes. RESEARCH DESIGN AND METHODS: Using Medicare claims data (April 2013-December 2017), we identified 83...

Full description

Bibliographic Details
Main Authors: Hawley, C.E (Author), Kim, S.C (Author), Lauffenburger, J.C (Author), Paik, J.M (Author), Patorno, E. (Author), Wexler, D.J (Author)
Format: Article
Language:English
Published: NLM (Medline) 2022
Subjects:
aged
Aged
Diabetes Mellitus, Type 2
female
Female
human
Humans
hydroxymethylglutaryl coenzyme A reductase inhibitor
Hydroxymethylglutaryl-CoA Reductase Inhibitors
medicare
Medicare
Medication Adherence
medication compliance
non insulin dependent diabetes mellitus
Retrospective Studies
retrospective study
Sodium-Glucose Transporter 2 Inhibitors
United States
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items